| Astrocytes | |
|---|---|
| Allen Atlas ID | CS202210140_3650 |
| Lineage | Glial > Astroglia |
| Markers | GFAP, AQP4, SLC1A2, SLC1A3, ALDH1L1, S100B |
| Brain Regions | Widespread (all brain regions), Protoplasmic (gray matter) and fibrous (white matter) |
| Disease Vulnerability | Alzheimer's Disease, ALS, Alexander Disease, Multiple Sclerosis |
[Astrocytes[/entities/[astrocytes[/entities/[astrocytes[/entities/[astrocytes--TEMP--/entities)--FIX-- is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Astrocytes## Overview
**** are the most abundant glial cell type in the mammalian brain, comprising approximately 20-40% of total brain cells. These multifaceted cells are essential for normal brain function, providing structural support, metabolic nourishment, synaptic maintenance, and participating in numerous neural signaling processes. Astrocytes are critically involved in the pathogenesis of neurodegenerative diseases including [Alzheimer's Disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--, [ALS[/diseases/[als[/diseases/[als[/diseases/[als--TEMP--/diseases)--FIX--, [Alexander Disease[/diseases/[alexander-disease[/diseases/[alexander-disease[/diseases/[alexander-disease--TEMP--/diseases)--FIX--, and [Multiple Sclerosis[/diseases/[multiple-sclerosis[/diseases/[multiple-sclerosis[/diseases/[multiple-sclerosis--TEMP--/diseases)--FIX-- [1].
| Astrocytes | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allen Atlas ID | cortex
¶ Molecular Markers¶ Classical Markers
¶ Specialized Markers
¶ Normal Functions¶ Homeostatic Support
¶ Neurotransmitter CyclingAstrocytes are essential for neurotransmitter recycling:
¶ Synaptic FunctionAstrocytes actively participate in synaptic transmission:
¶ Blood-Brain Barrier SupportAstrocyte endfeet cover >95% of cerebral vasculature:
¶ CNS Development
¶ Astrocyte Reactivity¶ Reactive Astrocyte StatesIn response to CNS injury or disease, astrocytes undergo reactive changes: A1 Reactive Astrocytes (Neurotoxic)
A2 Reactive Astrocytes (Neuroprotective)
¶ Molecular SignaturesA1 astrocytes express:
A2 astrocytes express:
¶ Role in Neurodegenerative Diseases¶ Alzheimer's DiseaseAstrocytes contribute to AD pathogenesis through multiple mechanisms:
¶ Amyotrophic Lateral Sclerosis (ALS)Astrocytes in ALS exhibit:
¶ Multiple SclerosisAstrocytes in MS:
¶ Parkinson's DiseaseAstrocyte involvement in PD:
¶ Alexander Disease[Astrocyte-specific disease[/diseases/[alexander-disease[/diseases/[alexander-disease[/diseases/[alexander-disease--TEMP--/diseases)--FIX-- caused by GFAP mutations:
¶ Therapeutic Implications¶ Targeting Astrocyte Dysfunction
¶ Transcriptomic ProfileSingle-cell RNA sequencing has revealed astrocyte diversity:
The Allen Cell Type Atlas provides detailed transcriptomic data for astrocyte populations [3]. ¶ Key Publications
¶ External Links
¶ See Also
¶ BackgroundThe study of Astrocytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. ¶ Research Evidence¶ AD✓ Established Fluorescence excitation/emission spectra of amyloid-binding dyes, when analyzed with machine learning (PCA, UMAP, neural networks), can distinguish distinct conformational amyloid strains in vitro and in situ Successfully identified 6 distinct conformational strains in vitro with 98% discrimination; validated on transgenic mouse models and human brain samples showing distinct clustering for different disease types Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ◉ Supported Different neurodegenerative diseases (sAD, fAD PSEN1, fAD APP, Down syndrome) have distinct conformational strains of Aβ plaques that can be differentiated spectroscopically UMAP plots show 99% discrimination between sAD and fAD; fAD PSEN1 and fAD APP clusters overlap; DS forms separate cluster with patient-specific subclusters Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ◉ Supported Tau tangles from different neurodegenerative diseases (sAD, fAD, DS, Pick's disease) exist as distinct conformational strains PCA and UMAP show 5 distinct clusters for tau tangles across diseases; fAD PSEN1 and fAD APP share cluster suggesting same tau strain induced by different Aβ backgrounds; PiD tau clearly separated from AD tau Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ¶ FTD✓ Established Fluorescence excitation/emission spectra of amyloid-binding dyes, when analyzed with machine learning (PCA, UMAP, neural networks), can distinguish distinct conformational amyloid strains in vitro and in situ Successfully identified 6 distinct conformational strains in vitro with 98% discrimination; validated on transgenic mouse models and human brain samples showing distinct clustering for different disease types Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ◉ Supported Different neurodegenerative diseases (sAD, fAD PSEN1, fAD APP, Down syndrome) have distinct conformational strains of Aβ plaques that can be differentiated spectroscopically UMAP plots show 99% discrimination between sAD and fAD; fAD PSEN1 and fAD APP clusters overlap; DS forms separate cluster with patient-specific subclusters Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ◉ Supported Tau tangles from different neurodegenerative diseases (sAD, fAD, DS, Pick's disease) exist as distinct conformational strains PCA and UMAP show 5 distinct clusters for tau tangles across diseases; fAD PSEN1 and fAD APP share cluster suggesting same tau strain induced by different Aβ backgrounds; PiD tau clearly separated from AD tau Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ¶ PD✓ Established Fluorescence excitation/emission spectra of amyloid-binding dyes, when analyzed with machine learning (PCA, UMAP, neural networks), can distinguish distinct conformational amyloid strains in vitro and in situ Successfully identified 6 distinct conformational strains in vitro with 98% discrimination; validated on transgenic mouse models and human brain samples showing distinct clustering for different disease types Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ◉ Supported Different neurodegenerative diseases (sAD, fAD PSEN1, fAD APP, Down syndrome) have distinct conformational strains of Aβ plaques that can be differentiated spectroscopically UMAP plots show 99% discrimination between sAD and fAD; fAD PSEN1 and fAD APP clusters overlap; DS forms separate cluster with patient-specific subclusters Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ◉ Supported Tau tangles from different neurodegenerative diseases (sAD, fAD, DS, Pick's disease) exist as distinct conformational strains PCA and UMAP show 5 distinct clusters for tau tangles across diseases; fAD PSEN1 and fAD APP share cluster suggesting same tau strain induced by different Aβ backgrounds; PiD tau clearly separated from AD tau Source: Yang, Hyunjun et al., EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains (2023) DOI:10.1073/pnas.2300769120 ¶ none○ Speculative The unique composition of the telencephalon's oligodendrocyte lineage might be relevant for understanding and treating diseases like multiple sclerosis The paper notes that oligodendrocytes differ between telencephalon and rest of brain, with Type 1 predominating in telencephalon and Type 2 increasing posteriorly. The authors suggest this could be relevant for diseases like MS, though this is not tested experimentally. Source: Siletti, Kimberly et al., Transcriptomic diversity of cell types across the adult human brain (2023) DOI:10.1101/2022.10.12.511898 ○ Speculative Deeper sampling in mouse brain would reveal similar neuronal complexity to that observed in human splatter neurons The authors note they identified subclusters likely conserved across species, suggesting that deeper sampling will reveal similar neuronal complexity in the mouse, though they acknowledge their previous work did not uncover equivalent complexity in mice. Source: Siletti, Kimberly et al., Transcriptomic diversity of cell types across the adult human brain (2023) DOI:10.1101/2022.10.12.511898 ◉ Supported The complexity of splatter neurons reflects under-sampling rather than inherent biological complexity The authors propose that the immense complexity of splatter neurons reflects highly reproducible cell types and that their data likely under-samples neurons in hypothalamus, midbrain, and hindbrain which control innate behaviors and physiological functions. Source: Siletti, Kimberly et al., Transcriptomic diversity of cell types across the adult human brain (2023) DOI:10.1101/2022.10.12.511898 ¶ References
Page auto-generated from NeuroWiki cell type database. Last updated: 2026-03-05. | |||||||||||||||||||||